2323 Chung Hsing Announces Disposal of Securities

Release Date: September 16, 2026 Statement Date: September 15, 2026 Statement Time: 17:21:48 Company Code: 2323 Company Name: Chung Hsing Subject: Announcement of Disposal of Securities by the Company Applicable Clause: Item 20 Factual Date: September 15, 2026 Details: 1. Security Name: UniPharma Ordinary Shares 2. Transaction Period: 09/10/2026 ~ 09/15/2026 3. Board Approval Date: Not applicable 4. Other Approval Dates: Approval Level: Approved by Chairman September 15, 2026 (R.O.C. Year 115) 5. Quantity, Unit Price, and Total Transaction Amount: Quantity (in thousands of shares): 118 Unit Price (NT$): 2,743.13 Total Transaction Amount (NT$): 323,689,368 6. Gain (or Loss) on Disposal (not applicable for acquisition): Disposal Loss: NT$6,981,622 7. Relationship with Target Company: None 8. Cumulative Holdings (including this transaction) to Date: Remaining Holdings: 180,500 shares, Value: NT$511,141,380 Ownership Percentage: 0.18%, Rights Restrictions: None 9. Proportion of Securities Investment (including this transaction) under Article 3 of the 'Asset Acquisition or Disposal Rules for Publicly Issued Companies' to Total Assets and Equity Attributable to Owners of Parent in Latest Financial Statements, and Operating Capital: Percentage of Total Assets: 86.12% Percentage of Equity Attributable to Owners of Parent: 115.8% Operating Capital: NT$8,285,327 thousand 10. Specific Purpose of Acquisition or Disposal: Investment Portfolio Adjustment 11. Directors Who Objected to This Transaction: None 12. Whether This Transaction Is a Related-Party Transaction: No 13. Counterparty and Relationship with the Company: Not applicable 14. Date of Supervisor Approval or Audit Committee Consent: Not applicable 15. Previous Material Information Disclosure Date for the Same Event: Not applicable 16. Other Disclosures: Authorized designated traders on June 30, 2026 (R.O.C. Year 115) to conduct securities transactions in the centralized market during Q3 2026